FDA confirms Johnson & Johnson vaccine prevented all deaths and hospitalizations in trial
The United States could be days away from getting a third COVID-19 vaccine.
A Food and Drug Administration review has confirmed that Johnson & Johnson's COVID-19 vaccine, which only requires a single shot, is safe and effective, meaning it could be authorized for emergency approval "as soon as this weekend," The Washington Post reports.
The FDA review showed the vaccine was 66 percent effective at preventing moderate to severe COVID-19 in a large clinical trial, though it was 85 percent effective at preventing severe illness. As Johnson & Johnson previously announced, the vaccine also "demonstrated complete protection against COVID-related hospitalization and death, 28 days post-vaccination." That, University of Rochester School of Medicine and Dentistry's Nancy M. Bennett told the Post, is "really what's important."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Johnson & Johnson vaccine comes with the key benefit of only requiring one dose, as opposed to two doses for both the Pfizer and Moderna vaccines that were previously authorized for emergency approval in the United States. Plus, the Johnson & Johnson vaccine can also be stored for three months in a refrigerator, rather than having to be kept frozen, The Associated Press notes.
A committee is set to meet Friday to consider whether the FDA should authorize the Johnson & Johnson vaccine for emergency approval. The company says that should the FDA do so, it expects to begin shipping the vaccine immediately and "deliver enough single-doses by the end of March to enable the vaccination of more than 20 million Americans."
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
DOJ settles with Nassar victims for $138M
Speed Read The settlement includes 139 sexual abuse victims of the former USA Gymnastics doctor
By Justin Klawans, The Week US Published
-
14 recent scientific breakthroughs
In Depth From photos of the infant universe to an energy advancement that could save the planet
By Devika Rao, The Week US Published
-
Who will win the 2024 presidential election?
In Depth Election year is here. Who are pollsters and experts predicting to win the White House?
By Justin Klawans, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published